4613v1 -- 4149 => (4193,5747,7157,648)

Westermark UK, Wilhelm M, Frenzel A, Henriksson MA

The MYCN oncogene and differentiation in neuroblastoma.

Semin Cancer Biol 21:256-66 (2011)
DOI:10.1016/j.semcancer.2011.08.001

Bell E, Chen L, Liu T, Marshall GM, Lunec J, Tweddle DA

MYCN oncoprotein targets and their therapeutic potential.

Cancer Lett 293:144-57 (2010)
DOI:10.1016/j.canlet.2010.01.015

Slack A, Chen Z, Tonelli R, Pule M, Hunt L, Pession A, Shohet JM

The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.

Proc Natl Acad Sci U S A 102:731-6 (2005)
DOI:10.1073/pnas.0405495102

Beierle EA, Trujillo A, Nagaram A, Kurenova EV, Finch R, Ma X, Vella J, Cance WG, Golubovskaya VM

N-MYC regulates focal adhesion kinase expression in human neuroblastoma.

J Biol Chem 282:12503-16 (2007)
DOI:10.1074/jbc.M701450200

Chen L, Iraci N, Gherardi S, Gamble LD, Wood KM, Perini G, Lunec J, Tweddle DA

p53 is a direct transcriptional target of MYCN in neuroblastoma.

Cancer Res 70:1377-88 (2010)
DOI:10.1158/0008-5472.CAN-09-2598

Ochiai H, Takenobu H, Nakagawa A, Yamaguchi Y, Kimura M, Ohira M, Okimoto Y, Fujimura Y, Koseki H, Kohno Y, Nakagawara A, Kamijo T

Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.

Oncogene 29:2681-90 (2010)
DOI:10.1038/onc.2010.22